Ephrin‑B2 inhibits cell proliferation and motility in vitro and predicts longer metastasis‑free survival in breast cancer von Magic, Zeljana, Sandstrom, Josefine, Perez-Tenorio, Gizeh

Volltext

Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature von Johansson, Annelie, Yu, Nancy Y., Iftimi, Adina, Tobin, Nicholas P., 't Veer, Laura, Nordenskjöld, Bo, Benz, Christopher C., Fornander, Tommy, Perez‐Tenorio, Gizeh, Stål, Olle, Esserman, Laura J., Yau, Christina, Lindström, Linda S.

Volltext

Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data von Zardavas, Dimitrios, Te Marvelde, Luc, Milne, Roger L, Fumagalli, Debora, Fountzilas, George, Kotoula, Vassiliki, Razis, Evangelia, Papaxoinis, George, Joensuu, Heikki, Moynahan, Mary Ellen, Hennessy, Bryan T, Bieche, Ivan, Saal, Lao H, Stal, Olle, Iacopetta, Barry, Jensen, Jeanette Dupont, O'Toole, Sandra, Lopez-Knowles, Elena, Barbaraeschi, Mattia, Noguchi, Shinzaburo, Azim, Jr, Hatem A, Lerma, Enrique, Bachelot, Thomas, Wang, Qing, Perez-Tenorio, Gizeh, Can de Velde, Cornelis J H, Rea, Daniel W, Sabine, Vicky, Bartlett, John M S, Sotiriou, Christos, Michiels, Stefan, Loi, Sherene

Volltext

Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Can... von MILLER MARIANELA PEREZ-TORRES, Todd W, NARASANNA, Archana, ARTEAGA, Carlos L, GUIX, Marta, STAL, Olle, PEREZ-TENORIO, Gizeh, GONZALEZ-ANGULO, Ana M, HENNESSY, Bryan T, MILLS, Gordon B, KENNEDY, J. Phillip, LINDSLEY, Craig W

Volltext

IP6K2 predicts favorable clinical outcome of primary breast cancer von Sandström, Josefine, Balian, Alien, Lockowandt, Rebecca, Fornander, Tommy, Nordenskjöld, Bo, Lindström, Linda, Pérez-Tenorio, Gizeh, Stål, Olle

Volltext

The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype von Veenstra, Cynthia, Karlsson, Elin, Mirwani, Sanam Mirwani, Nordenskjöld, Bo, Fornander, Tommy, Pérez-Tenorio, Gizeh, Stål, Olle

Volltext

PIK3CA Mutations and PTEN Loss Correlate with Similar Prognostic Factors and Are Not Mutually Exclusive in Breast Cancer von Perez-Tenorio, Gizeh, Alkhori, Liza, Olsson, Birgit, Waltersson, Marie Ahnstroem, Nordenskjoeld, Bo, Rutqvist, Lars Erik, Skoog, Lambert, Staal, Olle

Volltext

The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patien... von Karlsson, Elin, Pérez-Tenorio, Gizeh, Amin, Risul, Bostner, Josefine, Skoog, Lambert, Fornander, Tommy, Sgroi, Dennis C, Nordenskjöld, Bo, Hallbeck, Anna-Lotta, Stål, Olle

Volltext

Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands von Falivelli, Giulia, Lisabeth, Erika Mathes, Rubio de la Torre, Elena, Perez-Tenorio, Gizeh, Tosato, Giovanna, Salvucci, Ombretta, Pasquale, Elena B

Volltext

High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1 von Karlsson, Elin, Waltersson, Marie Ahnström, Bostner, Josefine, Pérez-Tenorio, Gizeh, Olsson, Birgit, Hallbeck, Anna-Lotta, Stål, Olle

Volltext

GATA3 and markers of epithelial-mesenchymal transition predict long-term benefit from tamoxifen in ER-positive breast cancer von Sandström, Josefine, Bomanson, Jens, Pérez-Tenorio, Gizeh, Jönsson, Carolin, Nordenskjöld, Bo, Fornander, Tommy, Lindström, Linda S., Stål, Olle

Volltext

VAV3 mediates resistance to breast cancer endocrine therapy von Aguilar, Helena, Urruticoechea, Ander, Halonen, Pasi, Kiyotani, Kazuma, Mushiroda, Taisei, Barril, Xavier, Serra-Musach, Jordi, Islam, Abul, Caizzi, Livia, Di Croce, Luciano, Nevedomskaya, Ekaterina, Zwart, Wilbert, Bostner, Josefine, Karlsson, Elin, Pérez Tenorio, Gizeh, Fornander, Tommy, Sgroi, Dennis C, Garcia-Mata, Rafael, Jansen, Maurice P H M, García, Nadia, Bonifaci, Núria, Climent, Fina, Soler, María Teresa, Rodríguez-Vida, Alejo, Gil, Miguel, Brunet, Joan, Martrat, Griselda, Gómez-Baldó, Laia, Extremera, Ana I, Figueras, Agnes, Balart, Josep, Clarke, Robert, Burnstein, Kerry L, Carlson, Kathryn E, Katzenellenbogen, John A, Vizoso, Miguel, Esteller, Manel, Villanueva, Alberto, Rodríguez-Peña, Ana B, Bustelo, Xosé R, Nakamura, Yusuke, Zembutsu, Hitoshi, Stål, Olle, Beijersbergen, Roderick L, Pujana, Miguel Angel

Volltext

ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2‑positive metastatic breast cancer treated with trastuzumab von Ellegård, Sander, Veenstra, Cynthia, Pérez-Tenorio, Gizeh, Fagerström, Victor, Gårsjö, Jon, Gert, Krista, Sundquist, Marie, Malmström, Annika, Wingren, Sten, Elander, Nils O, Hallbeck, Anna-Lotta, Stål, Olle

Volltext

Akt kinases in breast cancer and the results of adjuvant therapy von Stål, Olle, Pérez-Tenorio, Gizeh, Akerberg, Linda, Olsson, Birgit, Nordenskjöld, Bo, Skoog, Lambert, Rutqvist, Lars Erik

Volltext

EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer von Husa, Anna-Maria, Magić, Željana, Larsson, Malin, Fornander, Tommy, Pérez-Tenorio, Gizeh

Volltext

Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer von Karlsson, Elin, Veenstra, Cynthia, Emin, Shad, Dutta, Chhanda, Pérez-Tenorio, Gizeh, Nordenskjöld, Bo, Fornander, Tommy, Stål, Olle

Volltext

Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer von Pérez-Tenorio, Gizeh, Karlsson, Elin, Waltersson, Marie Ahnström, Olsson, Birgit, Holmlund, Birgitta, Nordenskjöld, Bo, Fornander, Tommy, Skoog, Lambert, Stål, Olle

Volltext

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial von Johansson, Annelie, Dar, Huma, van 't Veer, Laura J, Tobin, Nicholas P, Perez-Tenorio, Gizeh, Nordenskjöld, Anna, Johansson, Ulla, Hartman, Johan, Skoog, Lambert, Yau, Christina, Benz, Christopher C, Esserman, Laura J, Stål, Olle, Nordenskjöld, Bo, Fornander, Tommy, Lindström, Linda S

Volltext

Met and its ligand HGF are associated with clinical outcome in breast cancer von Veenstra, Cynthia, Pérez-Tenorio, Gizeh, Stelling, Anna, Karlsson, Elin, Mirwani, Sanam Mirwani, Nordensköljd, Bo, Fornander, Tommy, Stål, Olle

Volltext

Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial von Johansson, Annelie, Dar, Huma, Nordenskjöld, Anna, Perez-Tenorio, Gizeh, Tobin, Nicholas P, Yau, Christina, Benz, Christopher C, Esserman, Laura J, van 't Veer, Laura J, Nordenskjöld, Bo, Stål, Olle, Fornander, Tommy, Lindström, Linda S

Volltext